Stocks and Investing Stocks and Investing
Fri, August 27, 2021
Thu, August 26, 2021

Joseph Schwartz Maintained (ASND) at Buy with Increased Target to $182 on, Aug 26th, 2021


Published on 2024-10-27 17:46:57 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $178 to $182 on, Aug 26th, 2021.

Joseph has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joseph


  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $189 on, Monday, June 14th, 2021
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, June 1st, 2021
Contributing Sources